Japan Tissue Engineering Co., Ltd. (TYO:7774)
Japan · Delayed Price · Currency is JPY 843.00
+12.00 (1.44%)
Oct 6, 2026, 3:30 PM JST
Japan Tissue Engineering Market Cap
Japan Tissue Engineering has a market cap or net worth of 33.75 billion as of October 5, 2026. Its market cap has increased by 69.25% in one year.
Market Cap
33.75B
Enterprise Value
30.40B
Revenue
2.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
843.00
ChartMarket Cap Chart
Since December 21, 2007, Japan Tissue Engineering's market cap has increased from 5.99B to 33.75B, an increase of 463.17%. That is a compound annual growth rate of 9.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 33.75B | 33.60% |
| Dec 30, 2025 | 25.26B | 34.34% |
| Dec 30, 2024 | 18.80B | -8.50% |
| Dec 29, 2023 | 20.55B | 8.35% |
| Dec 30, 2022 | 18.96B | -17.49% |
| Dec 30, 2021 | 22.99B | -8.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SanBio Company | 73.69B |
| Heartseed | 61.81B |
| Cuorips | 58.43B |
| 3-D Matrix | 53.88B |
| Healios K.K. | 39.31B |
| Innovacell | 26.19B |
| Stella Pharma | 16.74B |
| RaQualia Pharma | 15.80B |